Federal contractor · TUCSON, AZ

THE CRITICAL PATH INSTITUTE

THE CRITICAL PATH INSTITUTE received $193.4K in federal contract obligations in FY2026, on 3 awards (−79% vs FY2025). Since FY2017: $9.9M. Its largest customer was Food and Drug Administration ($193.4K). It also received $15.2M in federal grants and other assistance in FY2026.

Obligations · FY2026
$193.4K
New awards
3
Sole-source
0.0%
Single offer
100%
UEI
KAEPADMRKHD3
Other than small businessNonprofit
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 0FY2017
  2. 596.7KFY2018
  3. 3.8MFY2019
  4. 386.7KFY2020
  5. 373KFY2021
  6. 1.3MFY2022
  7. 818.5KFY2023
  8. 1.6MFY2024
  9. 900KFY2025
  10. 193.4KFY2026

Top buying agencies

Obligations in FY2026.

  1. Food and Drug Administration$193.4K100%
    3 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$193.4K100%

Where the work was performed

  1. Pima County, AZ$905.8K100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition100%
    US 39% · $923.8K
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions100%
    US 8.7% · $923.8K
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. BAA FOR DEVELOPMENT OF DRUG DEVELOPMENT TOOLS FOR ADTKD$2.8M
    Food and Drug Administration· Pima County, AZ· Research & development· Aug 16, 2024 – Aug 18, 2026· 75F40124C00106
  2. BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING$2.7M
    Food and Drug Administration· Pima County, AZ· Research & development· Sep 30, 2019 – Oct 30, 2025· 75F40119C10135
  3. BAA EETWP #63: A STANDARDIZED FRAMEWORK TO SUPPORT FDA QUALIFICATION OF COMPLEX IN VITRO MODELS FOR USE IN REGULATORY SUBMISSIONS.$1.7M
    Food and Drug Administration· Montgomery County, MD· Research & development· Sep 26, 2022 – May 11, 2026· 75F40122C00196

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

THE CRITICAL PATH INSTITUTE received $15.2M in federal assistance in FY2026, on 11 actions (1 new awards), −38% vs FY2025. Its largest program was 93.103 · Food and Drug Administration Research ($15.2M).

Assistance · FY2026
$15.2M
New awards
1
Actions
11
Since FY2021
$109.2M

Assistance by fiscal year

  1. 14.9MFY2021
  2. 21.4MFY2022
  3. 16.6MFY2023
  4. 16.6MFY2024
  5. 24.4MFY2025
  6. 15.2MFY2026

By type

  1. Grants$15.2M100%

Top programs

  1. 93.103 · Food and Drug Administration Research$15.2M100%

Awarding agencies

  1. Food and Drug Administration$15.2M100%
    Department of Health and Human Services

Largest awards

  1. CRITICAL PATH PUBLIC PRIVATE PARTNERSHIPS$121.8M
    93.103 · Food and Drug Administration Research· Food and Drug Administration· Cooperative agreement· Dec 21, 2020 – Sep 25, 2026· U18FD005320
  2. DEVELOPMENT OF A QUALIFICATION PLAN FOR THE VIRTUAL REALITY FUNCTIONAL CAPACITY ASSESSMENT TOOL - SHORT LIST (VRFCAT-SLX) (DDT COA #000004)…$499.9K
    93.103 · Food and Drug Administration Research· Food and Drug Administration· Cooperative agreement· Sep 2, 2024 – Jul 27, 2026· U01FD008424
  3. PSYCHOMETRIC ANALYSES AND QUANTITATIVE STUDY REPORT FOR QUALIFICATION OF THE CHRONIC HEART FAILURE SYMPTOM SCALE (CHF-SS) (DDT COA #000112)…$498.1K
    93.103 · Food and Drug Administration Research· Food and Drug Administration· Cooperative agreement· Sep 2, 2024 – Jul 27, 2026· U01FD008423
  4. PSYCHOMETRIC ANALYSES AND QUANTITATIVE STUDY REPORT FOR QUALIFICATION OF THE PEDIATRIC ASTHMA DIARY-CHILD (PAD-C) AND THE PEDIATRIC ASTHMA…$250K
    93.103 · Food and Drug Administration Research· Food and Drug Administration· Cooperative agreement· Sep 10, 2025 – Jul 27, 2026· U01FD008654
  5. C-PATH GLOBAL IMPACT CONFERENCE - ABSTRACT CRITICAL PATH INSTITUTE (C-PATH) IS AN INDEPENDENT, NONPROFIT PUBLIC-PRIVATE PARTNERSHIP (PPP)…$150K
    93.103 · Food and Drug Administration Research· Food and Drug Administration· Project grant· Aug 7, 2024 – Feb 5, 2026· R13FD008427

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

  • Sub-grants: $1.2M (2 subawards)

2 sub-recipients

  1. THE NATIONAL ORGANIZATION FOR RARE DISORDERS INC$1.1M89%
    QUINCY, MA · 1 subaward
  2. EVIDERA, INC.$128K11%
    BETHESDA, MD · 1 subaward

As a sub-recipient: who pays it · FY2026

No subawards reported to it in FY2026.

By fiscal year

  • FY2021: $4.2M paid out · $0 received
  • FY2022: $3.5M paid out · $0 received
  • FY2023: $5.1M paid out · $0 received
  • FY2024: $1.9M paid out · $346K received
  • FY2025: $1M paid out · $0 received
  • FY2026: $1.2M paid out · $0 received

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from FY2021.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

15 companies · $16.9M reported

  1. THE NATIONAL ORGANIZATION FOR RARE DISORDERS INC$9.2M
    DANBURY, CT · 6 subawards
  2. SOCIETY OF CRITICAL CARE MEDICINE$1.5M
    MOUNT PROSPECT, IL · 2 subawards
  3. THE JOHNS HOPKINS UNIVERSITY APPLIED PHYSICS LABORATORY LLC$1.2M
    LAUREL, MD · 3 subawards

Primes that pay it

1 company · $346K reported

  1. THE JOHNS HOPKINS UNIVERSITY APPLIED PHYSICS LABORATORY LLC$346K
    LAUREL, MD · 1 subaward

Showing the top 3 of each list. Open the profile for potential partners and the full lists.

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from 2021.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. APTARGROUP INC$3M+81% in FY2026
    CONGERS, NY · 100% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services
  2. EMERALD INNOVATIONS, INC.$2M
    CAMBRIDGE, MA · 73% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services
  3. NUDGE BG, INC.$1.7M
    THOUSAND OAKS, CA · 65% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.